{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T13:24:11Z","timestamp":1763990651588,"version":"3.45.0"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T00:00:00Z","timestamp":1748649600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Division of AIDS"},{"name":"Clinical Pharmacology Training Program"},{"DOI":"10.13039\/100012304","name":"Johns Hopkins University School of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012304","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institue of General Medical Sciences","award":["T32 GM066691"],"award-info":[{"award-number":["T32 GM066691"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Men who have sex with men are at high risk of human immunodeficiency virus (HIV) acquisition through unprotected receptive anal intercourse (RAI). Behaviorally congruent HIV preexposure prophylaxis (PrEP) has long been advocated by individuals who find adherence challenging or prefer minimizing systemic drug concentrations. We developed an event-driven, behaviorally congruent rectal tenofovir douche as a PrEP option for RAI and demonstrated product safety\/acceptability in a previous clinical study. Here, our goal was to compare colorectal distribution of an HIV surrogate and tenofovir douche when the tenofovir douche preceded or followed simulated RAI (sRAI).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Five participants completed 2 paired study visits. At visit one, participants received an 111indium-diethylenetriaminepentaacetic acid-labelled tenofovir douche prior to sRAI using 99mTc-sulfur colloid in autologous semen as HIV surrogate. At visit two, the radiolabeled tenofovir douche was administered following radiolabeled sRAI. Colorectal distribution of both douche and HIV surrogate radioisotopes were assessed using single-photon emission computed tomography\/transmission computed tomography. Systemic permeability was assessed by plasma TFV concentrations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Colorectal distribution of the douche was not different between sequences. Conversely, the majority of HIV surrogate was within the rectosigmoid when the douche was administered prior to sRAI, but the distribution extended into descending colon when the douche was administered following sRAI. Regardless of sequence, an early plasma TFV peak 20\u2005minutes after dosing was observed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Douching following RAI may increase HIV distribution in the colon with uncertain impact on HIV acquisition risk. The early plasma TFV suggests even more rapid time to protection than reported in prior studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical Trials Registration<\/jats:title>\n                    <jats:p>NCT04195776.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/infdis\/jiaf286","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T07:42:43Z","timestamp":1748504563000},"page":"588-595","source":"Crossref","is-referenced-by-count":0,"title":["Anal Sex and Tenofovir Douche Sequence Impacts Colorectal Distribution of HIV Surrogate and Douche: DREAM-02"],"prefix":"10.1093","volume":"232","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5797-8128","authenticated-orcid":false,"given":"Ruohui","family":"Zheng","sequence":"first","affiliation":[{"name":"Division of Clinical Pharmacology, Department of Medicine, Johns Hopkins University School of Medicine , Baltimore, Maryland ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward J","family":"Fuchs","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology, Department of Medicine, Johns Hopkins University School of Medicine , Baltimore, Maryland ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6413-7191","authenticated-orcid":false,"given":"Sridhar","family":"Nimmagadda","sequence":"additional","affiliation":[{"name":"Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine , Baltimore, Maryland ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa C","family":"Rohan","sequence":"additional","affiliation":[{"name":"School of Pharmacy, University of Pittsburgh , Pittsburgh, Pennsylvania ,","place":["USA"]},{"name":"Magee-Womens Research Institute , Pittsburgh, Pennsylvania ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Pharmacy, University of Pittsburgh , Pittsburgh, Pennsylvania ,","place":["USA"]},{"name":"Magee-Womens Research Institute , Pittsburgh, Pennsylvania ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3992-5620","authenticated-orcid":false,"given":"Lynn N","family":"Bertagnolli","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology, Department of Medicine, Johns Hopkins University School of Medicine , Baltimore, Maryland ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3544-1319","authenticated-orcid":false,"given":"Sandra","family":"Massih","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology, Department of Medicine, Johns Hopkins University School of Medicine , Baltimore, Maryland ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0793-9497","authenticated-orcid":false,"given":"Brian S","family":"Caffo","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health , Baltimore, Maryland ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5696-8665","authenticated-orcid":false,"given":"Craig W","family":"Hendrix","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology, Department of Medicine, Johns Hopkins University School of Medicine , Baltimore, Maryland ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,5,31]]},"reference":[{"key":"2025112408220900600_jiaf286-B1","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1093\/ije\/dyq057","article-title":"HIV transmission risk through anal intercourse: systematic review, meta-analysis and implications for HIV prevention","volume":"39","author":"Baggaley","year":"2010","journal-title":"Int J Epidemiol"},{"key":"2025112408220900600_jiaf286-B2","doi-asserted-by":"crossref","first-page":"e25664","DOI":"10.1002\/jia2.25664","article-title":"Preference for using a variety of future HIV pre-exposure prophylaxis products among men who have sex with men in three US cities","volume":"24","author":"Mansergh","year":"2021","journal-title":"J Int AIDS Soc"},{"key":"2025112408220900600_jiaf286-B3","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1007\/s10461-007-9301-0","article-title":"The use of rectal douches among HIV-uninfected and infected men who have unprotected receptive anal intercourse: implications for rectal microbicides","volume":"12","author":"Carballo-Dieguez","year":"2008","journal-title":"AIDS Behav"},{"key":"2025112408220900600_jiaf286-B4","doi-asserted-by":"crossref","first-page":"e0284339","DOI":"10.1371\/journal.pone.0284339","article-title":"A randomized trial of safety, acceptability and adherence of three rectal microbicide placebo formulations among young sexual and gender minorities who engage in receptive anal intercourse (MTN-035)","volume":"18","author":"Bauermeister","year":"2023","journal-title":"PLoS One"},{"key":"2025112408220900600_jiaf286-B5","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1007\/s10461-017-1959-3","article-title":"Rectal douching associated with receptive anal intercourse: a literature review","volume":"22","author":"Carballo-Dieguez","year":"2018","journal-title":"AIDS Behav"},{"key":"2025112408220900600_jiaf286-B6","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1056\/NEJMoa1506273","article-title":"On-demand preexposure prophylaxis in men at high risk for HIV-1 infection","volume":"373","author":"Molina","year":"2015","journal-title":"N Engl J Med"},{"key":"2025112408220900600_jiaf286-B7","doi-asserted-by":"crossref","first-page":"e554","DOI":"10.1016\/S2352-3018(22)00133-3","article-title":"Daily and on-demand HIV pre-exposure prophylaxis with emtricitabine and tenofovir disoproxil (ANRS PREVENIR): a prospective observational cohort study","volume":"9","author":"Molina","year":"2022","journal-title":"Lancet HIV"},{"key":"2025112408220900600_jiaf286-B8","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1056\/NEJMoa1506110","article-title":"Use of a vaginal ring containing dapivirine for HIV-1 prevention in women","volume":"375","author":"Baeten","year":"2016","journal-title":"N Engl J Med"},{"key":"2025112408220900600_jiaf286-B9","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1126\/science.1193748","article-title":"Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women","volume":"329","author":"Abdool Karim","year":"2010","journal-title":"Science"},{"key":"2025112408220900600_jiaf286-B10","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s10508-013-0203-0","article-title":"Enema use among men who have sex with men: a behavioral epidemiologic study with implications for HIV\/STI prevention","volume":"43","author":"Noor","year":"2014","journal-title":"Arch Sex Behav"},{"key":"2025112408220900600_jiaf286-B11","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1093\/infdis\/jiad535","article-title":"Tenofovir douche as HIV preexposure prophylaxis for receptive anal intercourse: safety, acceptability, pharmacokinetics, and pharmacodynamics (DREAM 01)","volume":"229","author":"Weld","year":"2024","journal-title":"J Infect Dis"},{"key":"2025112408220900600_jiaf286-B12","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1089\/aid.2013.0189","article-title":"Isoosmolar enemas demonstrate preferential gastrointestinal distribution, safety, and acceptability compared with hyperosmolar and hypoosmolar enemas as a potential delivery vehicle for rectal microbicides","volume":"29","author":"Leyva","year":"2013","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2025112408220900600_jiaf286-B13","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1089\/aid.2016.0318","article-title":"Lubricant provides poor rectal mucosal HIV coverage","volume":"33","author":"Shieh","year":"2017","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2025112408220900600_jiaf286-B14","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1089\/aid.2016.0167","article-title":"A comparative pre-phase I study of the impact of gel vehicle volume on distal colon distribution, user experience, and acceptability","volume":"33","author":"Weld","year":"2017","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2025112408220900600_jiaf286-B15","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000003401","article-title":"Mapping colorectal distribution of cell-free and cell-associated HIV surrogates following simulated anal intercourse to aid rectal microbicide development [published online ahead of print 12 February 2024]","author":"Weld","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2025112408220900600_jiaf286-B16","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/QAI.0b013e3182373b5e","article-title":"Distribution of cell-free and cell-associated HIV surrogates in the colon after simulated receptive anal intercourse in men who have sex with men","volume":"59","author":"Louissaint","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2025112408220900600_jiaf286-B17","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1089\/aid.2015.0098","article-title":"A phase 1 randomized, blinded comparison of the pharmacokinetics and colonic distribution of three candidate rectal microbicide formulations of tenofovir 1% gel with simulated unprotected sex (CHARM-02)","volume":"31","author":"Hiruy","year":"2015","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2025112408220900600_jiaf286-B18","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/sj.clpt.6100236","article-title":"Quantitative imaging and sigmoidoscopy to assess distribution of rectal microbicide surrogates","volume":"83","author":"Hendrix","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"2025112408220900600_jiaf286-B19","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/j.1365-2125.2012.04267.x","article-title":"Quantification of the spatial distribution of rectally applied surrogates for microbicide and semen in colon with SPECT and magnetic resonance imaging","volume":"74","author":"Cao","year":"2012","journal-title":"Br J Clin Pharmacol"},{"key":"2025112408220900600_jiaf286-B20","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1089\/aid.2015.0182","article-title":"Dose frequency ranging pharmacokinetic study of tenofovir-emtricitabine after directly observed dosing in healthy volunteers to establish adherence benchmarks (HPTN 066)","volume":"32","author":"Hendrix","year":"2016","journal-title":"AIDS Res Hum Retroviruses"},{"author":"US Food and Drug Administration","key":"2025112408220900600_jiaf286-B21"},{"key":"2025112408220900600_jiaf286-B22","doi-asserted-by":"crossref","first-page":"102894","DOI":"10.1016\/j.ebiom.2020.102894","article-title":"Single oral dose for HIV pre or post-exposure prophylaxis: user desirability and biological efficacy in macaques","volume":"58","author":"Massud","year":"2020","journal-title":"EBioMedicine"},{"key":"2025112408220900600_jiaf286-B23","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1093\/jac\/dkaa476","article-title":"Two-dose emtricitabine\/tenofovir alafenamide plus bictegravir prophylaxis protects macaques against SHIV infection","volume":"76","author":"Bekerman","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"2025112408220900600_jiaf286-B24","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1093\/infdis\/jiv334","article-title":"Protection against rectal chimeric simian\/human immunodeficiency virus transmission in macaques by rectal-specific gel formulations of maraviroc and tenofovir","volume":"212","author":"Dobard","year":"2015","journal-title":"J Infect Dis"},{"key":"2025112408220900600_jiaf286-B25","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/QAI.0b013e3182898392","article-title":"Comprehensive assessment of HIV target cells in the distal human gut suggests increasing HIV susceptibility toward the anus","volume":"63","author":"McElrath","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2025112408220900600_jiaf286-B26","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1001\/jama.2020.18936","article-title":"Management of Crohn disease: a review","volume":"325","author":"Cushing","year":"2021","journal-title":"JAMA"},{"key":"2025112408220900600_jiaf286-B27","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1093\/ibd\/izac146","article-title":"Crohn's disease patients uniquely contain inflammatory responses to flagellin in a CD4 effector memory subset","volume":"28","author":"Morgan","year":"2022","journal-title":"Inflamm Bowel Dis"},{"key":"2025112408220900600_jiaf286-B28","doi-asserted-by":"crossref","first-page":"e00969-19","DOI":"10.1128\/JVI.00969-19","article-title":"Differentiation into an effector memory phenotype potentiates HIV-1 latency reversal in CD4+ T cells","volume":"93","author":"Kulpa","year":"2019","journal-title":"J Virol"},{"key":"2025112408220900600_jiaf286-B29","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1097\/01.rlu.0000134995.55131.30","article-title":"Comparison of Tc99m-DTPA and indium-111 DTPA studies of baclofen pump function","volume":"29","author":"O\u2019Connell","year":"2004","journal-title":"Clin Nucl Med"},{"key":"2025112408220900600_jiaf286-B30","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.1111\/bcp.15310","article-title":"Population pharmacokinetics of tenofovir, emtricitabine and intracellular metabolites in transgender women","volume":"88","author":"Tanaudommongkon","year":"2022","journal-title":"Br J Clin Pharmacol"},{"key":"2025112408220900600_jiaf286-B31","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ijid.2020.06.037","article-title":"Plasma pharmacokinetics and urinary excretion of tenofovir following cessation in adults with controlled levels of adherence to tenofovir disoproxil fumarate","volume":"97","author":"Cressey","year":"2020","journal-title":"Int J Infect Dis"},{"key":"2025112408220900600_jiaf286-B32","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1128\/AAC.45.10.2733-2739.2001","article-title":"Phase I\/II trial of the pharmacokinetics, safety, and antiretroviral activity of tenofovir disoproxil fumarate in human immunodeficiency virus-infected adults","volume":"45","author":"Barditch-Crovo","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"2025112408220900600_jiaf286-B33","doi-asserted-by":"crossref","first-page":"e02173-20","DOI":"10.1128\/AAC.02173-20","article-title":"A phase I evaluation of the pharmacokinetics and tolerability of the HIV-1 maturation inhibitor GSK3640254 and tenofovir alafenamide\/emtricitabine in healthy participants","volume":"65","author":"Pene Dumitrescu","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"2025112408220900600_jiaf286-B34","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1592\/phco.24.11.970.36141","article-title":"Effect of tenofovir disoproxil fumarate on the pharmacokinetics and pharmacodynamics of total, R-, and S-methadone","volume":"24","author":"Smith","year":"2004","journal-title":"Pharmacotherapy"},{"key":"2025112408220900600_jiaf286-B35","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1177\/0091270007300951","article-title":"Steady-state pharmacokinetics of emtricitabine and tenofovir disoproxil fumarate administered alone and in combination in healthy volunteers","volume":"47","author":"Blum","year":"2007","journal-title":"J Clin Pharmacol"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiaf286\/63409023\/jiaf286.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/232\/3\/588\/63409023\/jiaf286.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/232\/3\/588\/63409023\/jiaf286.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T13:22:16Z","timestamp":1763990536000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/232\/3\/588\/8154209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,31]]},"references-count":35,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,5,31]]},"published-print":{"date-parts":[[2025,9,15]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiaf286","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"type":"print","value":"0022-1899"},{"type":"electronic","value":"1537-6613"}],"subject":[],"published-other":{"date-parts":[[2025,9,15]]},"published":{"date-parts":[[2025,5,31]]}}}